共 50 条
- [31] The Economic Burden of Relapse in Acute Myeloid Leukemia (AML): A Retrospective Analysis of US Commercial and Medicare Claims [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S181 - S181
- [35] Management of Acute Myeloid Leukemia (AML) in Older Patients [J]. Current Oncology Reports, 2020, 22
- [36] Second line azacitidine for elderly or infirmed patients with acute myeloid leukemia (AML) not eligible for allogeneic hematopoietic cell transplantation—a retrospective national multicenter study [J]. Annals of Hematology, 2017, 96 : 575 - 579
- [40] Durable Response with Venetoclax in Combination with Decitabine or Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML) [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S201 - S201